Nithya Desikan
2019
In 2019, Nithya Desikan earned a total compensation of $1.8M as Chief Commercial Officer at RHYTHM PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $145,117 |
|---|---|
| Option Awards | $1,286,061 |
| Salary | $379,063 |
| Total | $1,810,241 |
Desikan received $1.3M in option awards, accounting for 71% of the total pay in 2019.
Desikan also received $145.1K in non-equity incentive plan and $379.1K in salary.
Rankings
In 2019, Nithya Desikan's compensation ranked 6,419th out of 13,971 executives tracked by ExecPay. In other words, Desikan earned more than 54.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,419 out of 13,971 | 54th |
Division Manufacturing | 2,424 out of 5,698 | 58th |
Major group Chemicals And Allied Products | 885 out of 2,197 | 60th |
Industry group Drugs | 750 out of 1,883 | 60th |
Industry Pharmaceutical Preparations | 551 out of 1,395 | 61st |
Source: SEC filing on April 29, 2020.
Desikan's colleagues
We found two more compensation records of executives who worked with Nithya Desikan at RHYTHM PHARMACEUTICALS in 2019.